Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin-naive individuals with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin-naive individuals with type 2 diabetes mellitus

Published:2018-07-22 Issue:12 Volume:20 Page:2894-2898
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Frier Brian M.¹^ORCID,Landgraf Wolfgang²,Zhang Mei³,Bolli Geremia B.⁴^ORCID,Owens David R.⁵^ORCID

Affiliation:

1. BHF Centre for Cardiovascular Science; The Queen's Medical Research Institute, University of Edinburgh; Edinburgh UK

2. Sanofi; Frankfurt Germany

3. Sanofi US Inc.; Bridgewater New Jersey

4. Department of Medicine; University of Perugia; Perugia Italy

5. Diabetes Research Group Cymru, College of Medicine; University of Swansea; Swansea UK

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13450/fullpdf

Reference13 articles.

1. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

2. Health outcomes associated with initiation of basal insulin after 1, 2, or ≥3 oral antidiabetes drug(s) among managed care patients with type 2 diabetes;Levin;J Manag Care Spec Pharm,2015

3. Clinical and economic outcomes associated with the timing of initiation of basal insulin in patients with type 2 diabetes mellitus previously treated with oral antidiabetes drugs;Levin;Clin Ther,2016

4. A patient-level analysis of efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine added to oral antidiabetes agents in people with type 2 diabetes;DeVries;Eur Endocrinol,2014

5. Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: a pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials;Owens;Diabetes Res Clin Pract,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Digital Health Technologies for Insulin Initiation and Optimization for People With Type 2 Diabetes;Endocrine Practice;2022-08

2. Interplay of adenosine monophosphate‐activated protein kinase/sirtuin‐1 activation and sodium influx inhibition mediates the renal benefits of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: A novel conceptual framework;Diabetes, Obesity and Metabolism;2020-02-20

3. The importance of the initial period of basal insulin titration in people with diabetes;Diabetes, Obesity and Metabolism;2020-01-19